Shandong Xinhua Pharmaceutical Company Limited (HKG:0719)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
5.83
-0.03 (-0.51%)
Apr 3, 2025, 4:08 PM HKT
8.77%
Market Cap 9.23B
Revenue (ttm) 9.01B
Net Income (ttm) 500.19M
Shares Out 689.78M
EPS (ttm) 0.72
PE Ratio 8.10
Forward PE n/a
Dividend 0.29 (5.02%)
Ex-Dividend Date Sep 4, 2024
Volume 1,758,000
Average Volume 2,079,710
Open 5.80
Previous Close 5.86
Day's Range 5.76 - 5.88
52-Week Range 5.00 - 8.05
Beta -0.11
RSI 52.95
Earnings Date Mar 31, 2025

About HKG:0719

Shandong Xinhua Pharmaceutical Company Limited develops, manufactures, and sells bulk pharmaceuticals, preparations, and chemical products in the People’s Republic of China, the Americas, Europe, and internationally. It offers antipyretic and analgesic, cardiovascular and cerebrovascular, anti-infective, and central nervous drugs under the Xinhua brand; and contract manufacturing services for active pharmaceutical ingredients and pharmaceutical intermediates, OTC, and generics. The company also provides ibuprofen bulk pharmaceutical products; a... [Read more]

Sector Healthcare
Founded 1943
Employees 7,104
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 0719
Full Company Profile

Financial Performance

In 2024, HKG:0719's revenue was 8.47 billion, an increase of 4.51% compared to the previous year's 8.10 billion. Earnings were 470.02 million, a decrease of -5.33%.

Financial numbers in CNY Financial Statements

News

There is no news available yet.